Φορτώνει......
Targeted Delivery of siRNA Therapeutics to Malignant Tumors
Over the past 20 years, a diverse group of ligands targeting surface biomarkers or receptors has been identified with several investigated to target siRNA to tumors. Many approaches to developing tumor-homing peptides, RNA and DNA aptamers, and single-chain variable fragment antibodies by using phag...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Drug Deliv |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Hindawi
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700508/ https://ncbi.nlm.nih.gov/pubmed/29218233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6971297 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|